Harvard, MA, United States of America

Van Cherington


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Van Cherington

Introduction

Van Cherington is a notable inventor based in Harvard, MA (US), recognized for his significant contributions to the field of cellular transplantation. With a focus on reducing adverse side effects associated with this medical procedure, Cherington has developed innovative methods that enhance patient safety and treatment efficacy.

Latest Patents

Cherington holds a patent for "Methods for reducing adverse side effects associated with cellular transplantation." This patent addresses the challenges posed by the infusion of cells that express tissue factor, which can lead to complications such as hemorrhage. The methods outlined in his patent aim to mitigate these risks by reducing the biological activity of tissue factor in patients. Techniques include infusing fewer cells, administering tissue factor antagonists, and inhibiting the coagulation cascade.

Career Highlights

Cherington's career is marked by his dedication to advancing medical science through innovative research and development. His work has not only contributed to the understanding of cellular transplantation but has also paved the way for safer clinical practices. His patent reflects a commitment to improving patient outcomes in a complex medical landscape.

Collaborations

Cherington has collaborated with esteemed colleagues such as David R Hurwitz and Theofanis Galanopoulos. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their collective work.

Conclusion

Van Cherington's innovative methods for reducing adverse side effects in cellular transplantation exemplify the importance of research and invention in the medical field. His contributions continue to influence practices that prioritize patient safety and treatment effectiveness.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…